Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

Oxygen Transport in the Blood

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...

Hypoxia

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Acute Respiratory Failure-III

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...

Acute Respiratory Failure-IV

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026

Same author

FDA Approval of Epoprostenol to Treat Primary Pulmonary Hypertension.

Pulmonary circulation·2025

Same author

Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertension.

ERJ open research·2025

Same author

A double-blind randomized trial of hyperbaric oxygen for persistent symptoms after brain injury.

Scientific reports·2025

Same author

Introducing Historical Vignettes in <i>Pulmonary Circulation</i>.

Pulmonary circulation·2025

Same author

Carbon Monoxide Poisoning (Reprinted from the 2023 Hyperbaric Indications Manual 15<sup>th</sup> edition).

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2024

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Expired CO₂ Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

Hyperbaric oxygen for acute carbon monoxide poisoning.

Lindell K Weaver¹, Ramona O Hopkins, Karen J Chan

¹Department of Internal Medicine, Pulmonary and Critical Care Division, LDS Hospital, Salt Lake City, Utah 84143, USA. lweaver@ihc.com

The New England Journal of Medicine

|October 4, 2002

Summary

Hyperbaric-oxygen treatment significantly reduced cognitive sequelae after acute carbon monoxide poisoning. This therapy showed lasting benefits at 12 months, improving patient outcomes.

More Related Videos

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Expired CO₂ Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

Area of Science:

Neurology
Hyperbaric Medicine
Toxicology

Background:

Acute carbon monoxide poisoning frequently leads to long-term cognitive impairments.
Hyperbaric-oxygen therapy is a potential treatment for mitigating these sequelae.

Purpose of the Study:

To evaluate the efficacy of hyperbaric-oxygen treatment in reducing cognitive sequelae following acute carbon monoxide poisoning.

Main Methods:

A double-blind, randomized trial compared three hyperbaric-oxygen treatments versus one normobaric-oxygen treatment within 24 hours.
Neuropsychological tests assessed cognitive function at multiple time points up to 12 months post-enrollment.

Main Results:

Cognitive sequelae were less frequent at 6 weeks in the hyperbaric-oxygen group (25.0%) compared to the normobaric-oxygen group (46.1%), P=0.007.
Hyperbaric-oxygen treatment also showed reduced cognitive sequelae at 12 months (P=0.04).
Cerebellar dysfunction was associated with cognitive sequelae and was more prevalent in the normobaric-oxygen group.

Conclusions:

Three hyperbaric-oxygen treatments within 24 hours appear to decrease the risk of cognitive sequelae after acute carbon monoxide poisoning.
The benefits of hyperbaric-oxygen therapy were observed at both 6 weeks and 12 months post-poisoning.